Polling Questions


According to the webcast, Why Not? How to Incorporate Female Sexual Medicine into Your Busy Practice (Dr Rubin) and Treatments for Low Sexual Desire with Associated Distress in Pre and Postmenopausal Women (Dr Simon), the RECONNECT study of ~1,200 women diagnosed with HSDD self-administering either bremelanotide or placebo evidenced that:
 a. Compared with placebo women using bremelanotide had a significant reduction in distress
 b. Compared with placebo women using bremelanotide had significantly increased scores on the desire domain
 c. Bremelanotide was associated with significant improvements in arousal, lubrication, orgasm and satisfaction domain scores compared with placebo
 d. All of the above
 
 

Your answers are confidential and will be used for educational purposes only.

Submit